Sustainable Green Team, Ltd. (SGTM) Engages Anthony L.G. PLLC to Initiate FORM-10 Process to become Fully Reporting, Uplist, and assist with all SEC Legal Matters

ORLANDO, Fla., Nov. 16, 2020 (GLOBE NEWSWIRE) — Sustainable Green Team, Ltd. (OTC: SGTM) (“SGTM” or the “Company”), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, engages Anthony L.G., PLLC to initiate FORM-10 process to become fully reporting, uplist, and assist with all SEC legal matters. This engagement was made shortly after the Company’s wholly owned subsidiary, Mulch Manufacturing expanded its 2021 mulch contracts with Circle K convenient stores, a subsidiary of Alimentation Couche-Tard, Inc. (OTC: ANCUF) (ANCUF”).

After completing and posting the Company’s two year audit for years ending December 2018 and 2019 at the end of October, and 3rd quarter ending September 30, 2020 last week, the company is positioned and ready commence the FORM-10 process with its new highly referred firm, Anthony L.G. PLLC.

SGTM’s CEO and Director Tony Raynor states, “We have communicated with many firms since our audit completion to see whom would be best suited for our team, shareholders, and transpire our vision. After communicating with Laura Anthony and doing our due diligence, our team feels more confident then ever on achieving our ultimate goal to be listed on the NASDQ to maximize exposure and greater value.”

Anthony L.G. PLLC, is a comprehensive corporate, securities, and business transactional law firm. With a team of experienced attorneys to ensure that all aspects of corporate legal needs are satisfied whether completing an initial public offering, follow on offering, private placement, merger or acquisition or general business contracts and ongoing corporate maintenance. As the securities industry’s premier corporate and transactional law firm. 
To learn more please visit: http://www.anthonypllc.com

About Sustainable Green Team, Ltd. (SGTM)

Sustainable Green Team, Ltd. (“SGTM”), through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The Company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The Company’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting tree debris through its tree services division and collection sites and then, through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The Company plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and are positioned for rapid growth from the resulting synergistic opportunities identified. The Company’s customers include governmental, residential and commercial clients.

SGTM currently has two wholly owned subsidiaries to efficiently asses areas, recover, manufacture, and distribute:

National Storm Recovery, LLC

National Storm Recovery, LLC (“NSR”), is composed of a team that has expertise in dangerous tree removal, debris hauling and debris management. The Company’s management team assesses storms by deploying its mobile command center to designated sites and then strategizing with its national partners, which include government agencies, prime contractors and subcontractors.

Central Florida Arborcare (“CFA”), a DBA of NSR has spent more than 40 years perfecting their technique for proper tree care, removal, and services. From tree removal, stump grinding, tree care, grapple hauling, and storm recovery, CFA ensures properties remain safe and businesses can continue as usual.
To learn more please visit: https://www.centralfloridaarborcare.com

Mulch Manufacturing, Inc.

Mulch Manufacturing, Inc. (“MMI”), being vertically integrated receiving large volume of wood fiber recovered from Central Florida Arborcare to feed raw material needs, MMI has the product line and distribution system to address a substantial customer base which can be expanded.
To learn more please visit: https://mulchmfg.com

For additional information regarding SGTM’s operations, expansion plans and production facilities, view the Company’s presentation.

SAFE HARBOR ACT: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, listing on the CSE, including words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will” and other similar expressions, are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance or achievements to differ materially from anticipated results, performance or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter our forward-looking statements, whether as a result of new information, future events or otherwise. No information in this press release should be construed in any matter whatsoever as an indication of the future performance of the Company’s revenues, financial condition or stock price.

Company Contact:

Anthony Raynor
CEO & Director
407.886.8733 Office

Corporate Communications:

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]



Assembly Biosciences and Door Pharmaceuticals Sign Collaboration and Option Agreement to Develop a Novel Class of HBV Core Protein Modulators

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB) and Door Pharmaceuticals, LLC today announced that the companies have signed an exclusive, two-year collaboration and option agreement focused on the development of a novel class of hepatitis B virus (HBV) core protein modulators. Door Pharmaceuticals’ innovative discovery platform targets functions of core protein distinct from viral assembly and that have the potential to interfere with viral nucleic acid including cccDNA transcription, providing a strong complement to Assembly Bio’s current portfolio.

Under the terms of the agreement, Door Pharmaceuticals will build upon its previous efforts to lead and conduct new discovery research, which will be funded by Assembly Bio. In return for an up-front payment and success-based milestones and royalties, Assembly Bio will be granted an exclusive option to license compounds arising from the collaboration and will be responsible for the continued development and commercialization of optioned compounds. Financial details were not disclosed.

“Door Pharmaceuticals was established by our co-founder, Adam Zlotnick, whose research led to the successful discovery of the core inhibitor candidates that comprise Assembly Bio’s clinical program,” said William Delaney, PhD, Chief Scientific Officer, Virology of Assembly Biosciences. “Adam is a true innovator, and this collaboration is a natural continuation of our work together. We’re excited to build upon our current pipeline of HBV core inhibitors with additional contributions from a science-driven company that shares our passion and focus for bringing new treatment options to patients facing HBV.”

“I’m thrilled at the opportunity to once again contribute to the advancement of Assembly Bio’s core inhibitor platform under this new collaboration,” said Adam Zlotnick, PhD, Founder of Door Pharmaceuticals. “There is a clear mechanistic rationale for the potential role that core inhibitors can play in the treatment of HBV, and it is our hope and belief that the complementary mechanisms of action of these core protein modulators will offer an important therapeutic pathway towards HBV cure.”

About HBV

Chronic hepatitis B virus (HBV) infection is a debilitating disease of the liver that afflicts over 250 million people worldwide with up to 90 million people in China, as estimated by the World Health Organization. HBV is a global epidemic that affects more people than hepatitis C virus (HCV) and HIV infection combined—with a higher morbidity and mortality rate. HBV is a leading cause of chronic liver disease and need for liver transplantation, and up to one million people worldwide die every year from HBV-related causes.

The current standard of care for patients with chronic HBV infection is life-long suppressive treatment with medications that reduce, but do not eliminate, the virus, resulting in very low cure rates. There is a significant unmet need for new therapies to treat HBV.

About Assembly Biosciences

Assembly Biosciences, Inc. is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly Bio’s fully integrated platform, including a robust process for strain identification and selection, GMP manufacturing expertise and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. For more information, visit assemblybio.com.

About 
Door Pharmaceuticals

Door Pharmaceuticals was founded in 2018 by leading HBV researcher, Adam Zlotnick, PhD, a professor of molecular and cellular biochemistry at Indiana University; he is also a fellow of the American Academy of Microbiology and of the AAAS. The company is focused on research of virus structural proteins to discover new classes of inhibitors. The company is initially focused on HBV, with the vision to realize the potential for novel therapeutics for other viruses.

Forward-Looking Statements

The information in this press release contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to materially differ. These risks and uncertainties include: the Door collaboration may not yield any novel assets and we may not exercise our option with respect to any collaboration compounds; Assembly Bio’s ability to initiate and complete clinical trials involving its HBV therapeutic product candidates in the currently anticipated timeframes; safety and efficacy data from clinical studies may not warrant further development of Assembly Bio’s product candidates; clinical and nonclinical data presented at conferences may not differentiate Assembly Bio’s product candidates from other companies’ candidates; Assembly Bio may not observe sustained virologic response in patients who stop therapy in Study 211; Assembly Bio’s ability to maintain financial resources necessary to continue its clinical trials and fund business operations; any impact that the spread of the coronavirus and resulting COVID-19 pandemic may have on Assembly Bio’s business and operations, including initiation and continuation of its clinical trials or timing of discussions with regulatory authorities; and other risks identified from time to time in Assembly Bio’s reports filed with the U.S. Securities and Exchange Commission (the SEC). You are urged to consider statements that include the words may, will, would, could, should, might, believes, hopes, estimates, projects, potential, expects, plans, anticipates, intends, continues, forecast, designed, goal or the negative of those words or other comparable words to be uncertain and forward-looking. Assembly Bio intends such forward-looking statements to be covered by the safe harbor provisions contained in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. More information about Assembly Bio’s risks and uncertainties are more fully detailed under the heading “Risk Factors” in Assembly Bio’s filings with the SEC, including its most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K. Except as required by law, Assembly Bio assumes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

Contacts

Assembly Biosciences, Inc.
Lauren Glaser
Senior Vice President, Investor Relations and Corporate Affairs
(415) 521-3828
[email protected]

Media Contact
Sam Brown Inc.
Audra Friis
(917) 519-9577
[email protected]



PCG Advisory CEO Jeff Ramson Joins Virtual Fall Investor Summit Panel, “Making Smart Investment Decisions in Uncertain Times”

Panel to be Held on Wednesday, November 18
th
at 5:00 PM ET

NEW YORK, NY, Nov. 16, 2020 (GLOBE NEWSWIRE) — via NewMediaWire ‒ PCG Advisory, Inc., a leading New York City-based investor relations and digital strategies firm, today announced that CEO Jeff Ramson will join a panel at the Virtual Fall Investor Summit taking place on November 16- 18, 2020. 

The panel, “Making Smart Investment Decisions in Uncertain Times,” will take place on Wednesday, November 18th at 5:00 PM ET. Other panelists include Shree Viswanathan, founder of SVN Capital and Steve Kiel, founder and CIO of Arquitos Capital. The panel will be moderated by Vijay Chopra, Portfolio Manager, DCM Advisors, LLC.

“In these uncertain and fast changing times, I look forward to this discussion with my fellow panelists as we all continue to search for successful investment strategies,” Ramson said. “At PCG we have a long history of identifying hidden strength and value in smaller cap stocks with the potential to perform well in various market environments.” 

For more information about the Virtual Fall 2020 Investor Summit, which offers free admission for investors as attendees, go to:
https://fall-investor-summit2020.events.issuerdirect.com/login

About PCG Advisory, Inc.

PCG Advisory is a leading investor relations firm dedicated to the delivery of top-tier strategic services that encompass investor relations, capital markets navigation, and corporate communications for innovative and emerging companies from around the globe. PCG Advisory has extensive experience with life sciences, technology and other emerging growth companies.

PCG Advisory is part of PCG Holdings Inc. PCG Holdings also owns Proactive Capital Group LLC., which manages a global macro hedge fund called Proactive Capital Partners, LP.  The fund invests in a broad spectrum of financial instruments, including an allocation for emerging public companies.

Contact:

Stephanie Prince
Managing Director
(646) 762-4518
[email protected]



Enview Gains Unprecedented Momentum Following Release of Enview Explore; Demonstrates Operational Success with U.S. Air Force, Receives Strategic Contract with PACAF

Enview Explore Proves Tremendous Value in Field Exercise with U.S. Air Force, Awarded Operational Contract with PACAF

SAN FRANCISCO, Nov. 16, 2020 (GLOBE NEWSWIRE) — Enview, a pioneer in the scalable processing of 3D geospatial data, has experienced considerable momentum on the heels of its recent launch of Enview Explore. The powerful web application leverages AI and cloud computing to automatically process 3D data at unprecedented speed and scale, making it an invaluable tool for the U.S. Air Force.

The company was recently selected by the Commander of Pacific Air Forces (COMPACAF) for award of a Phase III SBIR contract to deploy Enview’s Geospatial AI platform in support of air bases throughout Indo-Pacific Command (INDOPACOM). Phase III contracts are not easily won as they denote technologies ready for operational use rather than dollars earmarked for research and development.

“This is particularly exciting for us as we’ve worked hard to deliver throughout the R&D stages of the SBIR process. Being able to support operational end-users is a core focus for us, and this Phase III contract allows us to do just that,” said Enview CEO San Gunawardana.

Enview recently joined USAF Advanced Battle Lab (ABL) personnel at Nellis Air Force Base to deploy Enview Explore at the Advanced Battle Management System (ABMS) Onramp 2 exercise.

“We were thrilled to have the opportunity to demonstrate the power of Enview Explore in the field during this exercise. Of particular excitement was witnessing LiDAR data being streamed to the ground as it was being collected. Within 35 minutes of the initial collect, we were able to process and visualize the data through Explore’s 3D common operating picture,” said John Dombzalski, VP of Public Sector at Enview. “Shortly thereafter, Explore automatically identified changes to terrain, buildings, and vehicles in support of runway damage assessment and search and rescue operations. When all was said and done, the near-real time change analysis concluded before the plane even landed. We’re excited to see how this level of speed and fidelity enhances agile combat employment and enables multi-domain battle managers to make more rapid and precise decisions.”

Enview was previously awarded an Air Force Phase II SBIR to automatically exploit airborne LiDAR for the purpose of route-navigation determination and infrastructure assessment for Air Force Special Operations Command (AFSOC) and Pacific Air Forces (PACAF). The company was further awarded an Air Force Phase II SBIR to enhance the Contingency Response Mission of Air Mobility Command (AMC) in post-disaster areas.

The company also recently appointed Robert Cardillo to its Board of Directors. Cardillo served as the sixth director of the National Geospatial-Intelligence Agency from 2014 through 2019, where he led the NGA under the authorities of the Secretary of Defense and Director of National Intelligence to transform the Agency’s value proposition through innovative partnerships with the growing commercial geospatial industry.

“Enview’s work with the U.S. Air Force is a testament to the value of scalable, AI-powered processing for 3D geospatial data in mission-critical use cases,” said Cardillo. “I’m excited to witness the innovative ways in which Enview Explore, and future solutions, provide value for not only government organizations, but Fortune 500 companies as well.”

Enview’s geospatial AI platform has been deployed at TRL 9 for Fortune 500 companies for the automated 3D mapping of terrain, buildings, vegetation, infrastructure, route planning, line of sight, change detection, and other bespoke requirements. The platform rapidly generates accurate 3D maps to enhance tactical and theater-level decision-making. Learn more here.

Resources

About Enview

Enview is pioneering next-generation AI to automatically transform 3D data into insights at unprecedented speed, scale, and detail. Public and private sector organizations use Enview to virtualize the physical world and derive insights to protect people and infrastructure, and enhance national security. For more information and a demo, visit www.enview.com. The company is growing to meet market demand and currently expanding its machine learning and data science teams. Visit www.enview.com/about/careers to learn more.

Media Contact

Tanya Carlsson
Offleash for Enview
(707) 529-6139
[email protected]  



Keweenaw Land Announces Availability of Third Quarter Earnings Report

IRONWOOD, Mich., Nov. 16, 2020 (GLOBE NEWSWIRE) — Keweenaw Land Association, Limited (OTC US: KEWL) today announced that its third quarter earnings report is available on its website under “Company Reports” or on the OTC Markets website.

Contact: Paula J. Aijala, Secretary, Keweenaw Land Association, Limited, [email protected]

About Keweenaw Land Association, Limited: Keweenaw is a forest products and land management company located in Ironwood, Michigan. Keweenaw has land holdings exceeding 183,000 surface acres and 400,000 acres of mineral rights, located predominantly in the western Upper Peninsula of Michigan and northern Wisconsin. Additional information is available on the Company’s website at www.keweenaw.com.

Forward-Looking Statements: This release contains forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties and should not be relied upon as predictions of future events or promises of a given course of action. A number of factors such as the ongoing Covid-19 pandemic, changing economic conditions, price fluctuations, land use, environmental and other governmental regulations, and risk of loss from natural disasters, could cause actual results to differ materially from those described in the forward-looking statements. As with any investment, past performance is not a guarantee of future results. The Company is currently not subject to the filing requirements of the Securities Exchange Act of 1934, as amended. The Company is categorized as “Pink Current Information” under the OTC Pink Sheets.



Enphase Energy Joins Forces with MSpectrum to Provide Solar Solutions in the Philippines

FREMONT, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) — Enphase Energy, Inc. (NASDAQ: ENPH), a global energy management technology company and the world’s leading supplier of microinverter-based solar-plus-storage systems, today announced that it has entered into an agreement with MSpectrum, a solar energy renewable provider with headquarters in Pasig, Philippines, to distribute Enphase products to residential and commercial installers across the Philippines. The Enphase IQ 7™ family of products is expected to be available via MSpectrum starting in the first quarter of 2021.

MSpectrum, the renewable energy division of Manila Electric Company (MERALCO), will distribute the Enphase IQ 7 family of microinverters, which includes IQ 7, IQ 7+™, IQ 7A™, and IQ 7X™, to residential and commercial installers. In addition, the solar systems will be outfitted with Enphase Envoy™ communications gateways, which connect an Enphase-based solar system to the Enphase Enlighten™ software monitoring platform and help make per-panel energy monitoring and insights for operations and maintenance easy.

“We are proud to provide Enphase Energy seventh-generation microinverters in the Philippines,” said Robert Pereja, chief operating officer of MSpectrum. “This next-generation technology will benefit solar customers through its high performance, flexibility, reliability, and most importantly, safety, due to the rapid shutdown device (RSD) built into Enphase microinverters. We aim to work with Enphase to revolutionize the solar industry in the Philippines and motivate more Filipinos to shift from traditional to renewable sources of energy.”

“Enphase’s track record of quality manufacturing, technology, and credibility were some of the major factors for us to join forces with the company,” said Michael Paul Miranda, managing director, 8AM Engineering Services. “As a solar installer in the Philippines, we are pleased that Enphase microinverters have built-in RSD protection, low voltage AC, a simple installation process, and distributed architecture. We look forward to working with Enphase to bring more solar solutions to the Philippines.”

The IQ 7 family of microinverters leverages Enphase’s unique software-defined architecture and semiconductor integration for excellent reliability and economies of scale. Enphase microinverters are subjected to a rigorous reliability and quality testing regimen with more than an aggregated one million hours of cumulative power-on testing to help ensure exceptional performance under heat, high humidity, salty air, and cold. The design is compatible with operating in hot, humid and coastal conditions such as those found in the Philippines.

“We are pleased to join forces with MSpectrum to distribute our products in the Philippines,” said Dave Ranhoff, chief commercial officer at Enphase Energy. “The country’s solar market has great potential for Enphase, particularly in the residential and small commercial rooftop market segment. We believe Enphase’s unique value proposition of high-output performance and flexible installation, as well as a safe low voltage all-AC system architecture and rapid shutdown capability, resonates well in the Philippines solar market.”

To learn more about the Enphase and MSpectrum distribution partnership in the Philippines, please visit MSpectrum’s booth at the virtual Future Energy Show Philippines from Nov. 16-17, 2020, where MSpectrum and Enphase will host Enphase product demonstrations, marking the beginning of the collaboration between Enphase and MSpectrum in the Philippines solar market.

About Enphase Energy, Inc.

Enphase Energy, a global energy technology company, delivers smart, easy-to-use solutions that connect solar generation, storage and management on one intelligent platform. The Company revolutionized solar with its microinverter technology and produces the world’s only truly integrated solar plus storage solution. Enphase has shipped more than 30 million microinverters, and approximately 1.3 million Enphase-based systems have been deployed in more than 130 countries. For more information, visit www.enphase.com and follow the company on Facebook, LinkedIn and Twitter.

Enphase Energy, Enphase, the E logo, Enphase Energized, IQ 7, IQ 7+, I 7A, IQ 7X, Envoy, Enlighten, and other trademarks or service names are the trademarks of Enphase Energy, Inc. Other names are for informational purposes and may be trademarks of their respective owners.

Forward-Looking Statements


This press release may contain forward-looking statements, including statements related to Enphase Energy’s  availability dates for its products, the expected performance and advantages of its technology and products, including quality, safety, reliability, life expectancy, the simplicity of installation, the ease of monitoring and maintenance, and the ability to future proof and scale systems; anticipated product adoption in the geographies and markets we target; and the capabilities and performance of its partners’ products and services. These forward-looking statements are based on Enphase’s current expectations and inherently involve significant risks and uncertainties. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of certain risks and uncertainties including those risks described in more detail in Enphase’s most recent Annual Report on Form 10-K and other documents on file with the SEC and available on the SEC’s website at www.sec.gov. Enphase Energy undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations, except as required by law.

Enphase
Energy
Contact:

Robin Yan
General Manager, Emerging Markets
[email protected]
+1 (650) 864-2666



Vital Farms to Participate in Investor Conferences

AUSTIN, Texas, Nov. 16, 2020 (GLOBE NEWSWIRE) — Vital Farms (the “Company) (NASDAQ: VITL), a Certified B Corporation that offers a range of ethically produced pasture-raised foods nationwide, today announced that Russell Diez-Canseco, Chief Executive Officer, and Jason Dale, Chief Financial Officer and Chief Operating Officer, will present at upcoming virtual investor conferences.

Today, Monday, November 16th, 2020, the Company will host a fireside chat discussion at the Jefferies West Coast Consumer Conference at 11:30 a.m. ET, or 10:30 a.m CT. The discussion can be accessed live at the “Events & Presentations” section of the Vital Farms Investor Relations site at https://investors.vitalfarms.com/investor-relations. The replay will be archived online for 90 days.

Tomorrow, Tuesday, November 17th, 2020, the Company will participate in a panel discussion on sustainability in the food sector at the Goldman Sachs Sustain Fall Symposium at 9:00 a.m. ET, or 8:00 a.m. CT. For more information, please contact your Goldman Sachs representative.

About Vital Farms

Vital Farms, a Certified B Corporation, offers a range of ethically produced pasture-raised foods nationwide. Started on a single farm in Austin, Texas, in 2007, Vital Farms is the leading U.S. brand of pasture-raised eggs and butter by retail dollar sales. Vital Farms’ ethics are exemplified by its focus on the humane treatment of farm animals and sustainable farming practices. In addition, as a Delaware Public Benefit Corporation, Vital Farms also prioritizes the long-term benefits of each of its stakeholders, including farmers and suppliers, customers and consumers, communities and the environment, and crew members and stockholders. Vital Farms’ pasture-raised products, including shell eggs, butter, hard-boiled eggs, ghee, egg bites and liquid whole eggs, are sold in approximately 16,000 stores nationwide.

Contact

ICR
Ashley DeSimone
[email protected]
646.677.1827



Vantage Drilling International Reports Third Quarter Results for 2020

HOUSTON, Nov. 16, 2020 (GLOBE NEWSWIRE) — Vantage Drilling International (“Vantage” or the “Company”) reported a net loss attributable to controlling interest of approximately $169.3 million or $12.91 per diluted share for the three months ended September 30, 2020, based on the weighted average shares outstanding after the conversion of our convertible notes in December 2019, as compared to a net loss attributable to controlling interest of $25.7 million or $5.14 per diluted share for the three months ended September 30, 2019.

The three months ended September 30, 2020 included a non-cash loss on impairment charge of $128.9 million on the carrying amount of our longer-term warm stacked drillship, the Titanium Explorer.

As of September 30, 2020, Vantage had approximately $179.2 million in cash, including $13.5 million of restricted cash, compared to $188.4 million in cash, including $13.1 million of restricted cash, as of June 30, 2020, and $242.9 million in cash, including $11.0 million of restricted cash at December 31, 2019.

Ihab Toma, CEO, commented. “I continue to be very proud of the Company’s performance during these challenging times. While the COVID-19 pandemic and the related global economic crisis continue to weigh on activity in the industry, I am pleased that we have been successful in adding backlog, namely on the Emerald Driller and the Soehanah. Our focus remains on operating safely and efficiently, delivering excellence for our esteemed clients, managing costs and conserving cash.”

Vantage, a Cayman Islands exempted company, is an offshore drilling contractor, with a fleet of three ultra-deepwater drillships and five premium jackup drilling rigs. Vantage’s primary business is to contract drilling units, related equipment and work crews primarily on a dayrate basis to drill oil and natural gas wells globally for major, national and independent oil and natural gas companies. Vantage also provides construction supervision services and preservation management services for, and will operate and manage, drilling units owned by others.

The information above includes forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934. These forward-looking statements are subject to certain risks, uncertainties and assumptions identified above or as disclosed from time to time in the company’s filings with the Securities and Exchange Commission. As a result of these factors, actual results may differ materially from those indicated or implied by such forward-looking statements. Vantage disclaims any intention or obligation to update publicly or revise such statements, whether as a result of new information, future events or otherwise.

Public & Investor Relations
Contact:

Douglas E. Stewart
Chief Financial Officer and General Counsel
Vantage Drilling International
C/O Vantage Energy Services, Inc.
777 Post Oak Blvd., Suite 800
Houston, Texas 77056
(281) 404-4700

Vantage Drilling International  
Consolidated Statement of Operations  
(In thousands, except per share data)  
(Unaudited)  
  Three Months Ended September 30,     Nine Months Ended September 30,  
  2020     2019     2020     2019  
Revenue                              
Contract drilling services $ 18,069     $ 35,830     $ 95,539     $ 101,575  
Contract termination revenue                     594,029  
Reimbursables and other   2,142       4,814       12,903       15,978  
Total revenue   20,211       40,644       108,442       711,582  
Operating costs and expenses                              
Operating costs   27,231       37,915       113,890       114,538  
General and administrative   3,829       6,644       15,715       86,014  
Depreciation   18,230       18,459       54,647       55,491  
Loss on impairment   128,876             128,876        
Total operating costs and expenses   178,166       63,018       313,128       256,043  
(Loss) income from operations   (157,955 )     (22,374 )     (204,686 )     455,539  
Other income (expense)                              
Interest income   41       4,245       853       113,614  
Interest expense and other financing charges   (8,510 )     (10,465 )     (25,531 )     (36,715 )
Other, net   (46 )     97       2,321       221  
Total other (expense) income   (8,515 )     (6,123 )     (22,357 )     77,120  
(Loss) income before income taxes   (166,470 )     (28,497 )     (227,043 )     532,659  
Income tax provision (benefit)   2,855       (2,749 )     4,752       15,852  
Net (loss) income   (169,325 )     (25,748 )     (231,795 )     516,807  
Net income (loss) attributable to noncontrolling interests   2       (28 )     16       (312 )
Net (loss) income attributable to shareholders $ (169,327 )   $ (25,720 )   $ (231,811 )   $ 517,119  
(Loss) earnings per share                              
Basic $ (12.91 )   $ (5.14 )   $ (17.68 )   $ 102.47  
Diluted $ (12.91 )   $ (5.14 )   $ (17.68 )   $ 102.14  
                               
Weighted average ordinary shares outstanding                              
Basic   13,115       5,000       13,115       5,047  
Diluted   13,115       5,000       13,115       5,063  
                               
Vantage Drilling International  
Supplemental Operating Data  
(Unaudited, in thousands, except percentages)  
   
  Three Months Ended September 30,     Nine Months Ended September 30,  
  2020     2019     2020     2019  
Operating costs and expenses                              
Jackups $ 11,820     $ 14,910     $ 48,962     $ 46,763  
Deepwater   11,958       18,103       50,828       50,409  
Operations support   2,177       3,014       7,631       9,474  
Reimbursables   1,276       1,888       6,469       7,892  
  $ 27,231     $ 37,915     $ 113,890     $ 114,538  
                               
Utilization                              
Jackups   40.0 %     98.4 %     62.2 %     96.8 %
Deepwater   28.2 %     41.3 %     45.1 %     41.0 %

Vantage Drilling International  
Consolidated Balance Sheet  
(In thousands, except share and par value information)  
(Unaudited)  
               
  September 30, 2020     December 31, 2019  
               
ASSETS              
Current assets              
Cash and cash equivalents $ 165,736     $ 231,947  
Restricted cash   8,952       2,511  
Trade receivables, net   39,110       46,504  
Inventory   51,311       48,368  
Prepaid expenses and other current assets   15,491       16,507  
Total current assets   280,600       345,837  
Property and equipment              
Property and equipment   803,405       1,002,968  
Accumulated depreciation   (264,240 )     (281,842 )
Property and equipment, net   539,165       721,126  
Operating lease ROU assets   4,463       6,706  
Other assets   11,161       17,068  
Total assets $ 835,389     $ 1,090,737  
               
LIABILITIES AND SHAREHOLDERS’ EQUITY              
Current liabilities              
Accounts payable $ 26,587     $ 49,599  
Other current liabilities   28,324       26,936  
Total current liabilities   54,911       76,535  
Long–term debt, net of discount and financing costs of $5,191 and $6,421, respectively   344,809       343,579  
Other long-term liabilities   15,219       17,532  
Commitments and contingencies              
Shareholders’ equity              
Ordinary shares, $0.001 par value, 50 million shares authorized; 13,115,026 shares issued and outstanding, respectively   13       13  
Additional paid-in capital   633,924       634,770  
Accumulated (deficit) earnings   (214,747 )     17,064  
Controlling interest shareholders’ equity   419,190       651,847  
Noncontrolling interests   1,260       1,244  
Total equity   420,450       653,091  
Total liabilities and shareholders’ equity $ 835,389     $ 1,090,737  

Vantage Drilling International
Consolidated Statement of Cash Flows
(In thousands)
(Unaudited)
  Nine Months Ended September 30,  
  2020     2019  
CASH FLOWS FROM OPERATING ACTIVITIES              
Net (loss) income $ (231,795 )   $ 516,807  
Adjustments to reconcile net (loss) income to net cash (used in) provided by operating activities              
Depreciation expense   54,647       55,491  
Amortization of debt financing costs   1,229       1,217  
Amortization of debt discount         5,354  
Amortization of contract value         1,643  
PIK interest on the Convertible Notes         5,779  
Share-based compensation expense   1,358       1,053  
Deferred income tax (benefit) expense   (36 )     59  
Loss on disposal of assets   52       109  
Gain on settlement of restructuring agreement   (2,278 )      
Loss on impairment   128,876        
Changes in operating assets and liabilities:              
Trade receivables, net   7,394       (8,036 )
Inventory   (1,924 )     (1,688 )
Prepaid expenses and other current assets   483       (2,046 )
Other assets   4,250       3,214  
Accounts payable   (20,734 )     2,320  
Other current liabilities and other long-term liabilities   (2,598 )     11,011  
Net cash (used in) provided by operating activities   (61,076 )     592,287  
CASH FLOWS FROM INVESTING ACTIVITIES              
Additions to property and equipment   (2,634 )     (7,229 )
Net cash used in investing activities   (2,634 )     (7,229 )
CASH FLOWS FROM FINANCING ACTIVITIES              
Contributions from holders of noncontrolling interests         1,181  
Debt issuance costs         (487 )
Net cash provided by financing activities         694  
Net (decrease) increase in unrestricted and restricted cash and cash equivalents   (63,710 )     585,752  
Unrestricted and restricted cash and cash equivalents—beginning of period   242,944       239,387  
Unrestricted and restricted cash and cash equivalents—end of period $ 179,234     $ 825,139  

 



The Children’s Place to Webcast Review of Third Quarter 2020 Financial Results

SECAUCUS, N.J., Nov. 16, 2020 (GLOBE NEWSWIRE) — The Children’s Place, Inc. (Nasdaq: PLCE) today announced that, in conjunction with the release of its third quarter 2020 financial results, you are invited to listen to the Company’s conference call on Thursday, November 19, 2020, beginning at 8:00 a.m. Eastern Time.

To access the webcast, visit http://investor.childrensplace.com. An archive of the webcast can be accessed two hours after the live call has concluded.

About The Children’s Place

The Children’s Place is the largest pure-play children’s specialty apparel retailer in North America. The Company designs, contracts to manufacture, sells at retail and wholesale, and licenses to sell fashionable, high-quality merchandise predominantly at value prices, primarily under the proprietary “The Children’s Place”, “Place”, “Baby Place,” and “Gymboree” brand names. As of August 1, 2020, the Company had 824 stores in the United States, Canada and Puerto Rico, online stores at www.childrensplace.comandwww.gymboree.com, and the Company’s international franchise partners had 276 international points of distribution in 19 countries.

Forward Looking Statements

This press release, contains or may contain forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to statements relating to the Company’s strategic initiatives and adjusted net income per diluted share. Forward-looking statements typically are identified by use of terms such as “may,” “will,” “should,” “plan,” “project,” “expect,” “anticipate,” “estimate” and similar words, although some forward-looking statements are expressed differently. These forward-looking statements are based upon the Company’s current expectations and assumptions and are subject to various risks and uncertainties that could cause actual results and performance to differ materially. Some of these risks and uncertainties are described in the Company’s filings with the Securities and Exchange Commission, including in the “Risk Factors” section of its annual report on Form 10-K for the fiscal year ended February 1, 2020 and supplemented by the “Risk Factors” sections of its quarterly reports on Form 10-Q for the fiscal quarter ended May 2, 2020 and the fiscal quarter ended August 1, 2020. Included among the risks and uncertainties that could cause actual results and performance to differ materially are the risk that the Company will be unsuccessful in gauging fashion trends and changing consumer preferences, the risks resulting from the highly competitive nature of the Company’s business and its dependence on consumer spending patterns, which may be affected by changes in economic conditions, the risks related to the COVID-19 pandemic, including the impact of the COVID-19 pandemic on our business or the economy in general (including decreased customer traffic, schools adopting remote and hybrid learning models, closures of businesses and other activities causing decreased demand for our products and negative impacts on our customers’ spending patterns due to decreased income or actual or perceived wealth, and the impact of the CARES Act and other legislation related to the COVID-19 pandemic, and any changes to the CARES Act or such other legislation), the risk that the Company’s strategic initiatives to increase sales and margin are delayed or do not result in anticipated improvements, the risk of delays, interruptions and disruptions in the Company’s global supply chain, including resulting from COVID-19 or other disease outbreaks, or foreign sources of supply in less developed countries or more politically unstable countries, the risk that the cost of raw materials or energy prices will increase beyond current expectations or that the Company is unable to offset cost increases through value engineering or price increases, various types of litigation, including class action litigations brought under consumer protection, employment, and privacy and information security laws and regulations, the imposition of regulations affecting the importation of foreign-produced merchandise, including duties and tariffs, and the uncertainty of weather patterns. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they were made. The Company undertakes no obligation to release publicly any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Contact:  Investor Relations (201) 558-2400 ext. 14500



Reflect Scientific Inc. Announces Third Quarter 2020 Financial Results

OREM, Utah, Nov. 16, 2020 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announces financial results for the third quarter and nine-month period ended September 30, 2020.

The year over year revenue for the three months ended September 30, 2020 saw a 66.5% increase from $366,431 to $610,155 and for the 9 months ended a 215% increase from $977,312 to $2,096,869. Gross margins for the 2020 third quarter were virtually unchanged at 71% compared to 72% for the same period in 2019. The complete filing can be seen at https://sec.report/otc/financial-report/262536.

Mr. Kim Boyce, CEO of Reflect Scientific Inc., remarked, “Continued strong interest in the Cryometrix ultralow temperature freezers and solvent chillers has driven our successful third quarter revenues. My expectation is that the market conditions fueling our sales will prevail well into the foreseeable future. The emergence of mRNA vaccines like COVID-19, therapeutic protein drugs and other biologicals requiring ultra-cold conditions for processing, storage or transportation will serve to create a solid revenue stream for the Cryometrix ultracold refrigeration solutions.”

About Reflect Scientific, Inc.

Reflect Scientific, Inc., based in Orem, Utah, the company develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets. Among Reflect Scientific’s products are low-temperature freezers and refrigerated systems for laboratory, transportation and computer server room uses. Visit www.reflectscientific.com for more information. See us on Twitter @ReflectSci and LinkedIn www.linkedin.com/company/reflect-scientific.

Forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the Company’s products, increased levels of competition for the Company, new products and technological changes, the Company’s dependence on third- party suppliers, and other risks detailed from time to time in the Company’s periodic reports.



Contact
Thomas Tait
801-607-1039
[email protected]